159.17
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$155.45
Offen:
$156.11
24-Stunden-Volumen:
449.89K
Relative Volume:
1.29
Marktkapitalisierung:
$10.51B
Einnahmen:
$3.55B
Nettoeinkommen (Verlust:
$370.24M
KGV:
29.05
EPS:
5.48
Netto-Cashflow:
$355.96M
1W Leistung:
+3.25%
1M Leistung:
+5.90%
6M Leistung:
+0.06%
1J Leistung:
+8.14%
Aptargroup Inc Stock (ATR) Company Profile
Firmenname
Aptargroup Inc
Sektor
Telefon
(815) 477-0424
Adresse
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Vergleichen Sie ATR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ATR
Aptargroup Inc
|
159.17 | 10.18B | 3.55B | 370.24M | 355.96M | 5.48 |
![]()
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-07 | Eingeleitet | Raymond James | Outperform |
2025-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
2024-10-14 | Hochstufung | Jefferies | Hold → Buy |
2024-04-29 | Hochstufung | William Blair | Mkt Perform → Outperform |
2024-01-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2021-08-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-04-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2020-10-14 | Eingeleitet | Seaport Global Securities | Neutral |
2020-04-27 | Hochstufung | BofA/Merrill | Neutral → Buy |
2020-03-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
2020-03-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-02-26 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2019-07-08 | Eingeleitet | Morgan Stanley | Overweight |
2019-04-05 | Bestätigt | BofA/Merrill | Underperform |
2019-02-27 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2018-05-18 | Eingeleitet | Jefferies | Hold |
2016-12-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
2016-10-13 | Eingeleitet | Jefferies | Hold |
2016-01-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2015-11-02 | Hochstufung | Deutsche Bank | Hold → Buy |
2015-09-15 | Hochstufung | BofA/Merrill | Neutral → Buy |
2015-05-01 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2013-02-19 | Bestätigt | Deutsche Bank | Hold |
2013-01-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2012-07-10 | Herabstufung | KeyBanc Capital Mkts | Buy → Hold |
2012-04-11 | Eingeleitet | KeyBanc Capital Mkts | Buy |
2011-06-13 | Hochstufung | KeyBanc Capital Mkts | Hold → Buy |
Alle ansehen
Aptargroup Inc Aktie (ATR) Neueste Nachrichten
What AptarGroup (ATR)'s Quarterly Dividend Declaration Means For Shareholders - simplywall.st
Cosmetic Packaging Market Top PlayersAptarGroup Inc., DS - openPR.com
What analysts say about AptarGroup Inc. stockDynamic investment opportunities - Autocar Professional
AptarGroup Inc. Stock Analysis and ForecastLightning-fast capital gains - jammulinksnews.com
What drives AptarGroup Inc. stock priceSuperior trading gains - jammulinksnews.com
Is AptarGroup Inc. a good long term investmentExceptional return forecasts - jammulinksnews.com
Wells Fargo Raises AptarGroup Price Target to $173.00, Maintains "Overweight" Rating - AInvest
Human Factors and Usability Engineering Services Market Top - openPR.com
SWK Holdings Finalizes Asset Sale to AptarGroup - MSN
Aptar Beauty and Clarins Launch the Ninth Generation of the Double Serum - Aptar
Aptar Beauty Wins Prestigious Packaging Innovation Award for Nomad Refill - Aptar
AptarGroup Acquires Manufacturing Capabilities from Mod3 Pharma - AInvest
AptarGroup Acquires Mod3 Pharma's Manufacturing Capabilities From SWK - MarketScreener
Aptar Pharma acquires clinical trial manufacturing capabilities By Investing.com - Investing.com Canada
Aptar Pharma acquires clinical trial manufacturing capabilities - Investing.com Australia
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition - Aptar
Aptar Closures at drinktec 2025: Introducing Next Generation of Tamper-Evident, Recycling-Ready Sports Beverage Closures - Aptar
AptarGroup's (NYSE:ATR) Dividend Will Be $0.45 - simplywall.st
AptarGroup (NYSE:ATR) Will Pay A Dividend Of $0.45 - Yahoo Finance
AptarGroup declares $0.45 quarterly dividend - Investing.com India
AptarGroup declares $0.45 quarterly dividend By Investing.com - Investing.com Canada
AptarGroup Keeps Quarterly Dividend at $0.45 a Share, Payable Aug. 14 to Holders of Record July 24 - MarketScreener
Aptar Declares Quarterly Dividend – July 2025 - Aptar
Aptar Declares Quarterly Dividend - MarketScreener
Aptar launches material science tech for to simultaneous moisture and oxygen control - Medical Design & Outsourcing
Aptar Develops Moisture and Oxygen Controlling Technology - Contract Pharma
Aptar’s Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices - BioSpace
AptarGroup Introduces Dual-Active Technology for Moisture and Oxygen Control - AInvest
AptarGroup (ATR) Unveils Innovative Dual-Active Technology for P - GuruFocus
Aptar's Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices - Lelezard
Aptar Unveils Dual-Active Material Science Technology To Protect Sensitive Pharma And Medical Devices From Moisture And Oxygen - 富途牛牛
Finanzdaten der Aptargroup Inc-Aktie (ATR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):